Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/14/25 16:00 | 2/13/25 | LLY | Health | Drug | Pharmaceutical Preparations | Lilly Endowment Inc | IN | T | 41 | S | -2,691,010 | 806.35 | 0 | -3,337 | 99,769 | D | ||||||||||||||||
2/12/25 16:15 | 2/10/25 | LLY | Health | Drug | Pharmaceutical Preparations | Skovronsky Daniel | IN | O | EVP,CSO, | 1 | S.d | -4,316 | 863.21 | 0 | -5 | 212 | D | |||||||||||||||
11/8/24 16:18 | 11/8/24 | LLY | Health | Drug | Pharmaceutical Preparations | Zakrowski Donald A | IN | O | SVP,Fina | 5 | S.d | -2,998 | 784.81 | 0 | -4 | 10 | D | |||||||||||||||
6/3/24 16:14 | 6/3/24 | LLY | Health | Drug | Pharmaceutical Preparations | Norton Johna | IN | O | EVP,Glob | 1 | S | -5,782 | 819.38 | 0 | -7 | 28 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |